On a more functional level, our research group provided evidence on downstream effects of KCNJ3 upregulation in breast cancer: Rezania et al. showed that MCF-7 cells display higher wound healing capacity, increased invasion towards chemoattractants and higher motility and velocity than controls upon stable overexpression of KCNJ3 [13]. Here, KCNJ3 is linked to breast cancer.